Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Cancer Research
|
January 1, 1976
Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells
A Nicolin, P Franco, C Testorelli, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1992
Therapeutic implications of antisense oligonucleotides
D Lattuada, M Mazzei, R Meazza, et al.
Nature
|
October 18, 1974
Cellular immune response to a drug-treated L5178Y lymphoma subline
A Nicolin, A Bini, E Coronetti, et al.
Bollettino Dell'Istituto Sieroterapico Milanese
|
January 1, 1976
[Pharmacological alteration of the antigenic properties of experimental leukemias detected by lymphocyte transformation]
C Testorelli, A Missiroli, F Di Padova, et al.
Cancer Research
|
April 1, 1987
Evaluation of growth fractions with monoclonal antibodies to human alpha-DNA polymerase
A Alama, A Nicolin, P F Conte, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1976
Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines
A Nicolin, A Bini, F Di Padova, et al.
Tumori
|
March 1, 1977
Influence of autologous serum on in vitro reactivity of peripheral lymphocytes of patients with breast cancer
A Missiroli, G Bandieramonte, F Di Padova, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
November 30, 2000
BCL-2 regulation targeting the AU-rich domain
A Bevilacqua, M C Ceriani, N Schiavone, et al.
British Journal of Cancer
|
March 1, 1983
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody
C Testorelli, G Canti, P Franco, et al.
International Journal of Immunopharmacology
|
January 1, 1983
In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays
P Franco, A Nicolin, L Ricci, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Cancer Research
|
January 1, 1976
Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells
A Nicolin, P Franco, C Testorelli, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1992
Therapeutic implications of antisense oligonucleotides
D Lattuada, M Mazzei, R Meazza, et al.
Nature
|
October 18, 1974
Cellular immune response to a drug-treated L5178Y lymphoma subline
A Nicolin, A Bini, E Coronetti, et al.
Bollettino Dell'Istituto Sieroterapico Milanese
|
January 1, 1976
[Pharmacological alteration of the antigenic properties of experimental leukemias detected by lymphocyte transformation]
C Testorelli, A Missiroli, F Di Padova, et al.
Cancer Research
|
April 1, 1987
Evaluation of growth fractions with monoclonal antibodies to human alpha-DNA polymerase
A Alama, A Nicolin, P F Conte, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1976
Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines
A Nicolin, A Bini, F Di Padova, et al.
Tumori
|
March 1, 1977
Influence of autologous serum on in vitro reactivity of peripheral lymphocytes of patients with breast cancer
A Missiroli, G Bandieramonte, F Di Padova, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
November 30, 2000
BCL-2 regulation targeting the AU-rich domain
A Bevilacqua, M C Ceriani, N Schiavone, et al.
British Journal of Cancer
|
March 1, 1983
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody
C Testorelli, G Canti, P Franco, et al.
International Journal of Immunopharmacology
|
January 1, 1983
In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays
P Franco, A Nicolin, L Ricci, et al.
Page
of 11